Pharmacological Management of Thrombosis: Current State and Future Strategies. [PDF]
Int J Mol SciMogielnicki A.
europepmc +1 more source
Pharmacological and Interventional Prevention and Treatment of Microvascular Obstruction Following Primary PCI in STEMI. [PDF]
J Cardiovasc Dev DisOcchipinti G +4 more
europepmc +1 more source
Cangrelor to facilitate epidural catheter removal after urgent antithrombotic therapy. [PDF]
J Anaesthesiol Clin PharmacolKumari A +3 more
europepmc +1 more source
Abciximab: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Revascularisation
Abciximab is a monoclonal antibody fragment that inhibits platelet aggregation through antagonism of glycoprotein IIb/IIIa. The drug is used in conjunction with heparin and aspirin to prevent ischaemic complications associated with percutaneous coronary ...
Rachel H. Foster, Christopher J. Dunn
core
Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article. [PDF]
Cardiovasc TherWang G +8 more
europepmc +1 more source
ApoC3 Attenuates Platelet Activation Through GPIIb/IIIa Receptor Interaction. [PDF]
CellsHolzer M +4 more
europepmc +1 more source
Red blood cell aggregation within a blood clot causes platelet-independent clot shrinkage. [PDF]
Blood AdvPeshkova AD +7 more
europepmc +1 more source
The role of CD40/CD40L signaling in vascular inflammation and aneurysm progression: a systematic review and evidence synthesis. [PDF]
Am J Transl ResWang X +5 more
europepmc +1 more source
Pseudothrombocytopenia and other conditions associated with spuriously low platelet counts. [PDF]
HaematologicaCattaneo M.
europepmc +1 more source
Deferred stent optimization in a patient with acute myocardial infarction and high thrombus burden. [PDF]
Postepy Kardiol InterwencyjnejZdzierak B +5 more
europepmc +1 more source